Amrinone, also known as inamrinone, is a selective phosphodiesterase III inhibitor that enhances cardiac contractility and reduces preload by preventing the degradation of intracellular cyclic adenosine… Read more
Amrinone, also known as inamrinone, is a selective phosphodiesterase III inhibitor that enhances cardiac contractility and reduces preload by preventing the degradation of intracellular cyclic adenosine monophosphate, making it an agent used in the management of acute heart failure. The comprehensive selection of reference standards available for this category includes the active pharmaceutical ingredient, alongside essential pharmacopeial impurities and related compounds, such as Amrinone Related Compounds A, B, and C. These high-quality reference materials are indispensable for pharmaceutical laboratories conducting rigorous impurity profiling, analytical testing, and method validation to ensure the quality and consistency of drug substance formulations. Whether used for quantifying degradation products or establishing baseline analytical benchmarks, these compounds provide the precision required for compliant quality control workflows in cardiac medication research and production.